Iredell W Inglehart, III, M.D.
Clinical Advisory Board
Iredell W Inglehart, III, M.D. is an internist and rheumatologist in solo private practice in Baltimore, MD and Assistant Professor, part-time in rheumatology at Johns Hopkins University School of Medicine. Dr. Iglehart is the inventor of Tonix’s patented technology using very low dose (VLD)-cyclobenzaprine at bedtime to treat fibromyalgia. Dr. Iglehart is former President of the Johns Hopkins Alumni Association and in that capacity served on the Johns Hopkins University Board of Trustees under Chairman Michael Bloomberg for four years. In private practice for over 22 years, he spends more time with fewer patients, and still makes neighborhood house-calls. Dr. Iglehart’s discovery of VLD-cyclobenzaprine’s effects was motivated by his appreciation of the importance of sleep quality in both his general medical and rheumatologic patients.
Dr. Iglehart graduated Princeton University cum laude in 1979 and earned his M.D. at the Johns Hopkins University School of Medicine in 1983. He completed his residency in internal medicine and fellowship in rheumatology at Johns Hopkins.